Literature DB >> 6300707

The World Health Organization. Histological typing of breast tumors.

.   

Abstract

The WHO Histological Classification of Breast Tumors, published in 1968 has been completely revised. This second edition provides a recommended nomenclature, definitions and code numbers for both tumors and tumor-like lesions. It aims at promoting uniformity in recording and reporting diagnoses in order to facilitate international and other comparisons.

Entities:  

Mesh：

Year:  1983        PMID： 6300707

Source DB:  PubMed          Journal:  Neoplasma        ISSN： 0028-2685            Impact factor:   2.575


  11 in total

1.  Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.

Authors:  Naoki Niikura; Jun Liu; Colleen M Costelloe; Shana L Palla; John E Madewell; Naoki Hayashi; Tse-Kuan Yu; Yutaka Tokuda; Richard L Theriault; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Oncologist       Date:  2011-05-31

2.  Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.

Authors:  Naoki Niikura; Jun Liu; Naoki Hayashi; Shana L Palla; Yutaka Tokuda; Gabriel N Hortobagyi; Naoto T Ueno; Richard L Theriault
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

3.  Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions.

Authors:  Kimihito Fujii; Rie Watanabe; Takahito Ando; Junko Kousaka; Yukako Mouri; Miwa Yoshida; Tsuneo Imai; Shogo Nakano; Takashi Fukutomi
Journal:  Biomed Rep       Date:  2017-10-19

4.  Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study.

Authors:  Jinzhong Sun; Chuang Chen; Wen Wei; Hongmei Zheng; Jingping Yuan; Y I Tu; Feng Yao; Lijun Wang; Xiaoli Yao; Juanjuan Li; Yan Li; Shengrong Sun
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

5.  Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.

Authors:  Naoki Niikura; Jun Liu; Naoki Hayashi; Elizabeth A Mittendorf; Yun Gong; Shana L Palla; Yutaka Tokuda; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

6.  Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients.

Authors:  Juliana Laino do Val Carneiro; Suzana Lucy Nixdorf; Mário Sérgio Mantovani; Ana Cristina da Silva do Amaral Herrera; Mateus Nobrega Aoki; Marla Karine Amarante; Bruno Alberto Fabris; Maria Helena Pelegrinelli Fungaro; Maria Angelica Ehara Watanabe
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

7.  Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.

Authors:  Andrea Camerini; Sara Donati; Paolo Viacava; Olimpia Siclari; Cheti Puccetti; Gianna Tartarelli; Chiara Valsuani; Filomena De Luca; Leonardo Martini; Andrea Cavazzana; Domenico Amoroso
Journal:  J Exp Clin Cancer Res       Date:  2011-04-11

8.  Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis.

Authors:  Naoki Niikura; Jun Liu; Naoki Hayashi; Shana L Palla; Yutaka Tokuda; Gabriel N Hortobagyi; Naoto T Ueno; Richard L Theriault
Journal:  Oncologist       Date:  2011-01-25

9.  c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.

Authors:  Peter Fritz; Cristina M Cabrera; Jürgen Dippon; Andreas Gerteis; Wolfgang Simon; Walter E Aulitzky; Heiko van der Kuip
Journal:  Breast Cancer Res       Date:  2005-03-21       Impact factor: 6.466

10.  Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.

Authors:  Samer Sawalhi; Marwa Al-Shatti
Journal:  Ann Saudi Med       Date:  2013 Mar-Apr       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.